Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-123184
Filing Date
2025-12-19
Accepted
2025-12-19 16:22:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 19044
2 EXHIBIT 99.1 tm2533935d1_ex99-1.htm EX-99.1 4122
  Complete submission text file 0001104659-25-123184.txt   25041
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

EIN.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 1250 PAGE MILL RD PALO ALTO CA 94304
Business Address 1250 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Subject) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90673 | Film No.: 251587851
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)